Completing data — refresh the page later to see the latest
351422-73-6NC(=O)c1cccc(B(O)O)c1WDGWHKRJEBENCE-UHFFFAOYSA-N351422-73-6DTXSID90372263Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
This chemical does not meet GHS hazard criteria for 2% (1 of 51) of reports.
Warning
H302 (92.2%): Harmful if swallowed [Warning Acute toxicity, oral];H315 (17.6%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (17.6%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (15.7%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 51 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Reported as not meeting GHS hazard criteria per 1 of 51 reports by companies.;There are 7 notifications provided by 50 of 51 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
UsesReactant involved in the synthesis of a variety of inhibitors including:Orally active phosphodiesterase 10A inhibitorsPyrimidine derivatives as TpI2 kinase inhibitorsPeptidomimetic inhibitors of STAT3 proteinReactant involved in:Oxidative cross-coupling with mercaptoacetylenesTrifluoromethylation via a Collidine trifluoromethylating agentSuzuki cross-coupling reactions
UsesReactant involved in the synthesis of a variety of inhibitors including:• ;Orally active phosphodiesterase 10A inhibitors1• ;Pyrimidine derivatives as TpI2 kinase inhibitors2• ;Peptidomimetic inhibitors of STAT3 protein3Reactant involved in:• ;Oxidative cross-coupling with mercaptoacetylenes4• ;Trifluoromethylation via a Collidine trifluoromethylating agent5• ;Suzuki cross-coupling reactions6
Usessuzuki reaction